Volume 7, Issue 3

New HIV/COVID Screening Protocols

In this issue:

How can HIV infection be better identified in the populations, most of which are underserved, that experience the majority of new HIV cases? How cost-effective are current screening strategies? Can screening for HIV be linked to education about PrEP? Are there benefits to linking HIV screening with COVID testing? What does the evidence say?

These are some of the topics key to curtailing the HIV epidemic that Dr. Luis Rubio from the University of California San Francisco School of Medicine explores in this issue of eHIV Review.

Learning objectives:

  • Explain current HIV screening strategies most appropriate to specific at-risk populations.
  • Describe the potential benefits of linking HIV screening and SARS-CoV-2 testing.

Author:

Luis Rubio, MD, MHS
Luis Rubio, MD, MHS

Assistant Professor
University of California San Francisco
San Francisco, CA

Program Directors:

Justin Alves, RN, FNP-BC, ACRN, CARN, CNE

Nurse Educator
Boston Medical Center
Boston, MA
(he/him/his)

Matthew Spinelli, MD, MAS

Assistant Professor
HIV, ID, and Global Medicine
Zuckerberg San Francisco General Hospital
San Francisco, California
(he/him/his)

Ethel D. Weld, MD, PhD

Assistant Professor of Medicine and Pharmacology and Molecular Sciences
Division of Infectious Diseases
Division of Clinical Pharmacology
Johns Hopkins School of Medicine
Baltimore, Maryland
(she/her/hers)

Length of activity:

1.0 hour Physicians
1.0 contact hour Nurses

Launch date: February 9, 2022
Expiration date: February 8, 2024